Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Cigna Corp.

Canary Speech’s Voice AI Can Help Detect Alzheimer’s With 40-Second Conversation

AI voice tech start-up Canary Speech is developing algorithmic models for detecting behavioral health, progressive neurological and cognitive diseases based on a 40-second recording of speech. Medtech Insight caught up with Canary CEO Henry O’Connell at DHIS West to learn more about the company and its plans.

Blue Shield Of California’s Pharmacy Benefit Overhaul Could Still See Boost From Transparency Legislation

The payor’s multiyear plan to ditch the traditional PBM model and use multiple vendors has drawn a lot of skepticism from other actors in the health care system, but Blue Shield is hoping that it can help give policymakers some momentum, VP Lum tells the Pink Sheet.

Interviews PBMs

Part D In 2024: Premium Increases, Shrinking Choices Signal Early Impact Of IRA Redesign

More impactful benefit changes coming in 2025; will destabilization among standalone plans follow?

Pink Sheet Perspectives Medicare

Five Key Points From Cell & Gene Meeting On The Mesa

The three-day meeting in Carlsbad, CA, included commentary from numerous executives and investors in the cell and gene therapy space. Here are some of the biggest takeaways.

Gene Therapy Market Access
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Services
UsernamePublicRestriction

Register